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Background: Intestinal protozoan infection is one of the main causes of gastrointestinal diseases. Protozoa are usually detected by direct 
smear microscopy, concentration techniques, or special stains; however, these techniques are labor-intensive and require well-trained technicians. 
Therefore, molecular techniques involving polymerase chain reaction (PCR) have been developed to satisfy the need for unbiased and rapid ana-
lytical methods with high sensitivity and specificity. In this study, the BD MAXTM Enteric Parasite Panel (EPP) (Becton, Dickinson and Company, USA), 
designed to detect Cryptosporidium parvum and/or hominis, Giardia lamblia, and Entamoeba histolytica, and the AllplexTM Gastrointestinal Para-
site Assays (AGPA) (Seegene Inc., Korea), designed to detect Cryptosporidium species, G. lamblia, E. histolytica, Blastocystis hominis, Dientamoe-
ba fragilis, and Cyclospora cayetanensis were compared to determine whether any of these assays could become a useful tool for detecting intes-
tinal protozoan infections in Korea.
Methods: We investigated 295 fecal samples using EPP and AGPA. Then we confirmed the positive results with the conventional and nested PCR. 
Consistent detection by conventional PCR, nested PCR, and one of the multiplex panels was considered “true positive.”
Results: Out of 295 samples, 17 were true positives for B. hominis and 2 were true positives for E. histolytica. EPP detected parasites in only two 
samples owing to its design; however, its true positive detection rate was 100% (2/2). AGPA detected parasites in 24 samples with 79.2% (19/24) 
true positives. 
Conclusions: The incidence of protozoan, especially B. hominis, infection may be more prevalent than expected. AGPA could be an effective tool 
for screening protozoan infections.
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한국인 환자에서 장관 감염성 원충의 검출을 위한 BD MAX 
Enteric Parasite Panel과 Seegene Allplex Gastrointestinal 
Parasite Assay의 비교 평가
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INTRODUCTION
Intestinal parasite infection is one of the main causes of gas-
trointestinal diseases [1]; however, parasitic infections in af-
fected patients have been underreported compared to bacte-
rial or viral infections [2]. Intestinal protozoan parasites cause 
various gastrointestinal symptoms, ranging from asymptomatic 
to life-threatening watery or hemorrhagic diarrhea [3, 4]. Most 
laboratories use the microscopic ova and parasite examination 
for stool parasite testing. Usually direct smear microscopy, con-
centration techniques [5], or special stains such as Modied 
Fields’ stain, Giemsa stain, or iron hematoxylin stain are needed 
to detect protozoans [6]; however, these techniques are labor-
intensive and require well-trained and highly skilled techni-
cians for optimal interpretation. Furthermore, protozoan para-
sites are difcult to identify especially when they are present 
in low numbers; therefore, microscopic examination is not ef-
fective for accurate detection of the parasites due to low diag-
nostic sensitivity and specificity [3, 7-10]. Hence, molecular 
techniques involving polymerase chain reaction (PCR) have 
been developed for detecting protozoa to satisfy the need for 
unbiased and rapid analytical methods with high sensitivity 
and specicity [11, 12].
Cryptosporidium, Blastocystis, Entamoeba, Giardia lamblia, 
and Dientamoeba fragilis are the predominant species associ-
ated with intestinal infection etiology globally [1]. The commer-
cially available multiplex panels, BD MAXTM Enteric Parasite Panel 
(EPP) (Becton, Dickinson and Company, Sparks, MD, USA) and 
AllplexTM Gastrointestinal Parasite Assays (AGPA) (Seegene Inc., 
Seoul, Korea), are designed to detect protozoans. EPP is designed 
to detect Cryptosporidium parvum and/or hominis, G. lamblia, 
and Entamoeba histolytica, which are the most common para-
sites in developed countries. AGPA is designed to detect Crypto-
sporidium parvum and/or hominis, G. lamblia, Entamoeba his-
tolytica, Blastocystis hominis, D. fragilis and Cyclospora cayeta-
nensis. 
In this study, we compared EPP and AGPA to determine whether 
any of these assays could become a useful tool for detecting intes-




A total of 295 fecal samples, including both loose and formed 
stool, from patients with symptoms of gastroenteritis or patients 
visiting for regular health check-up were collected from Septem-
ber 2017 to May 2018. Most of the 264 fecal samples from patients 
with gastroenteritis were not examined for intestinal parasites but 
were tested for bacterial or viral infections. The samples were 
stored at -80˚C until used for DNA extraction. This study was ap-
proved by the Institutional Review Board of the Severance Hospi-
tal (IRB no. 4-2016-0946).
2. DNA extraction
Genomic DNA from 295 fecal samples was extracted using the 
QIAamp DNA mini kit (QIAGEN GmbH, Hilden, Germany) ac-
cording to the manufacturer’s instructions. The DNA samples were 
stored at -20˚C until tested. 
3. Parasites detection using multiplex real-time PCR
The fecal samples were processed using fully automated real-
time PCR systems; EPP designed to detect Cryptosporidium par-
vum and/or hominis, G. lamblia, and Entamoeba histolytica, 
and AGPA designed to detect Cryptosporidium species, G. lam-
blia, E. histolytica, Blastocystis hominis, D. fragilis, and Cyclospora 
cayetanensis. The fecal samples were processed in accordance 
with the manufacturers’ instructions. For EPP, the stool sample 
was directly applied using inoculation loop; it took about 3–4 
hours to show the ct value, and the type of parasite was identied 
using an exclusive program. AGPA requires the extracted DNA for 
the real-time PCR, and it takes about 2–3 hours to get the result. 
4.  Confirming positive results of EPP and AGPA through 
conventional and nested PCRs
The conventional and nested PCRs were designed to conrm 
the positive results of EPP and AGPA, and the primers used are 
shown in Table 1. We originally designed the rst primer for B. 
hominis using Primer 3 software. Then we designed the second 
primers for the nested PCR using a free trial of Genious prime 
version 2019.1.1, downloaded from the website http://geneious.
com (Biomatters Ltd. Auckland, New Zealand). Each of the sec-
ond primers for amplication was selected with size ranging from 
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30 to 50 base pairs. PCR reaction was established with the follow-
ing conditions: pre-denaturing at 95˚C for 5 minutes, 35 cycles of 
denaturation at 96˚C for 30 seconds, gradient annealing at 57˚C for 
30 seconds, and extension at 72˚C for 1 minute, and a nal exten-
sion for 5 minutes at 72˚C. Consistent detection of parasites through 
conventional PCR, nested PCR, and one of the commercial multi-
plex panels was considered “true positive.” Any other results not 
conrmed by both conventional and nested PCR were considered 
“false positive.”
RESULTS
As shown in Table 2, EPP detected two E. histolytica (No. 101 
and No. 220) from 295 fecal samples (0.67%). AGPA detected para-
sites from 24 fecal samples out of 295 (8.14%) as follows: two E. his-
tolytica (No. 101 and No. 220), one sample with E. histolytica, C. 
parvum/hominis, and G. lamblia (No. 163), one sample with B. 
hominis and D. fragilis (No. 32), two G. lamblia, and 18 B. hominis. 
The 24 positive samples were re-tested using laboratory-de-
signed conventional and nested PCR methods (Table 2). Overall, 
19 out of 295 samples were positive, including 17 B. hominis and 
2 E. histolytica. EPP only detected 2 parasites due to its design, 
but it was 100% true positive (2/2). AGPA detected parasites from 
24 samples and 79.2% of the results were true positive (19/24). Five 
samples were considered false positive (No. 11, No. 22, No. 32, No. 
163, and No. 269). Among those, three samples (No. 22, No. 163, 
and No. 269) showed negative results. B. hominis was detected in 
sample No. 11 and No. 32; in sample 11, G. lamblia was originally 
detected by AGPA. In sample No. 32, B. hominis was detected 
without the presence of D. fragilis.
DISCUSSION
In this study, we compared the performance of two commer-
cial multiplex panels in detecting intestinal protozoa using clinical 
stool samples (N=295) and conrmed the results with the con-
Table 1. Conventional and nested PCR primers
Target Organism Forward primer sequence (5՛-3՛) Reverse primer sequence (5՛-3՛) Target Accession number of 
target sequence
Blastocystis hominis First primer GGAGAGGGAGCCTGAGAGAT ACTTGCCCTCCAATTGTTTATCG 18s rRNA KX908213.1
Second primer GAGATGGCTACCACATCCAA GGATTGGGTAATTTACGCGC
Cryptosporidium parvum First primer* TGTGTTCAATATCTCCCTGCAAA GCATGTCGATTCTAATTCAGCTG Cowp1 AB089292.1
Second primer TGTGTTCAATATCTCCCTGCA CTGGTGCCATACATTGTTGT
Giardia lamblia First primer* GAGGTCAAGAAGTCCGCCG CAAGGGACTTGCGGAAGTTT betagiardin XM_001705373.1
Second primer CGCCGACAACATGTACCT CATGGTGTCGATCTCCTCC
Entamoeba histolytica First primer* GCGGACGGCTCATTATAACA TGTCGTGGCATCCTAACTCA 18s rRNA X65163.1
Second primer CGGACGGCTCATTATAACAG ACAAACTGGATCGTCTCAAG
Dientamoeba fragilis First primer* TTAGACCTTAGACAACGGATGTCTTG TGTGCATTCAAAGATCGAACTTATC 18s rRNA JQ677163.1
Second primer CAACGGATGTCTTGGCTCT TGCAACGTTCTTCATCGTG
*The first primers of the parasites are from Won et al. [2]. 
Table 2. Comparison of two real-time PCR, conventional PCR, and 
nested PCR results
Sample No. EPP AGPA Conventional PCR Nested PCR
  3 Negative BH BH BH
  5 Negative BH BH BH
11 Negative GL BH BH
15 Negative BH BH BH
19 Negative BH BH BH
22 Negative GL Negative Negative
23 Negative BH BH BH
32 Negative BH, DF BH BH
38 Negative BH BH BH
42 Negative BH BH BH
65 Negative BH BH BH
77 Negative BH BH BH
89 Negative BH BH BH
90 Negative BH BH BH
91 Negative BH BH BH
97 Negative BH BH BH
101 EH EH EH EH
115 Negative BH BH BH
118 Negative BH BH BH
163 Negative GL, EH, CR Negative Negative
220 EH EH EH EH
238 Negative BH BH BH
268 Negative BH BH BH
269 Negative BH Negative BH
Abbreviations: EPP, BD MAXTM Enteric Parasite Panel; AGPA, AllplexTM Gastrointesti-
nal Parasite Assay; PCR, polymerase chain reaction; EH, Entamoeba histolytica; BH, 
Blastocystis hominis; GL, Giardia lamblia; CR, Cryptosporidium parvum/hominis; 
DF, Dientamoeba fragilis.
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ventional and nested PCRs. Many studies from outside of Asia have 
already approved the detection ability of EPP to be highly sensi-
tive and specic [10, 13, 14]. In this study, EPP effectively detected 
E. histolytica (sample No. 101 and No. 220), which were also de-
tected by AGPA. Additionally, EPP showed negative results from 
sample No. 22 and No. 163, which were consistent with the results 
of conventional and nested PCRs. Nevertheless, it is difcult to 
conclude that EPP’s specicity is excellent since negative results 
may be shown due to its inability for detecting other types of par-
asites. 
Despite the high sensitivity of EPP, AGPA could detect parasites 
from more fecal samples in this study since it is designed to detect 
B. hominis, G. lamblia, D. fragilis, E. histolytica, C. caytanensis, 
and Cryptoporidium spp. AGPA demonstrated high efcacy in 
detecting the parasites, especially B. hominis. Due to the kit’s de-
sign, AGPA can primarily be used to detect protozoan parasites 
more effectively than other kits [15]. Interestingly, AGPA detected 
B. hominis from 19 fecal samples with 2 false positives and 17 true 
positives. In brief, B. hominis was detected from 5.8% of fecal sam-
ples (17/295 samples). 
B. hominis is a gastrointestinal eukaryotic parasite found in hu-
man and many animals [16, 17]. Even though the prevalence of B. 
hominis in Korea is not well-known, it may be the most common 
human intestinal protozoan in the world [18], with a reported prev-
alence of more than 50% in developing countries [19]. It causes 
gastrointestinal symptoms, but in most cases, it is asymptomatic 
[4]. According to Salim et al., animal handlers have a higher risk of 
B. hominis infection [20]. 
In this study, three B. hominis positive samples (No. 38, No. 42, 
and No. 97) were from patients who submitted their stool for reg-
ular health check-up. Unfortunately, we could not identify if the 
patients were animal handlers and what gastrointestinal symp-
toms they might have experienced. Although treating asymptom-
atic patients colonized with B. hominis may not be needed [21], 
still, detecting B. hominis is clinically important in Korea due to 
the increase in the number of people raising pets in households, 
and the rising interest in fecal microbiota transplantation in hospi-
tals. Detecting B. hominis is one of the exclusion criteria for se-
lecting donors for fecal microbiota transplantation [22]. Not only 
microscopic examination but also culturing B. hominis is possi-
ble; however, since there are many difculties in using in vitro cul-
ture for diagnosing B. hominis [23], PCR methods can be helpful 
in situations such as selecting donors for fecal microbiota trans-
plantation. 
Therefore, despite EPP’s detection ability, it may not be the right 
choice for detecting intestinal parasites in Korean clinical setting; 
however, AGPA could possibly be used for screening purposes 
since it can help the laboratory to detect B. hominis from fecal 
samples. We could not examine all the fecal samples microscopi-
cally, and further investigations could not be implemented due to 
the deterioration of the samples. Fresh fecal samples for both mi-
croscopic examination and RT-PCR assays may improve the de-
tection of intestinal parasites. Additionally, sequencing PCR prod-
ucts may help in conrming the type of parasites, therefore, fur-
ther studies comparing RT-PCR and sequencing results are needed. 
Meanwhile, owing to the lack of prevalent parasites in Korea 
for both assays, complementary microscopic examination would 
be needed to increase the detection rate of parasites. Ironically, 
however, low prevalence of parasites makes it more difcult to 
create new detection methods. It is the reason why AGPA could 
not receive approval from the South Korea Ministry of Food and 
Drug Safety (MFDS), and the development of new multiplex PCR 
to detect prevalent parasites such as C. sinensis and M. yokoga-
wai is difcult. Despite the difculties, PCR-based methods, which 
can be effectively used in laboratories in Korean hospitals, should 
be developed to manage parasitic infections. 
요 약
배경: 장내 원충 감염은 위장관계 질환의 주요 원인 중 하나이다. 
일반적으로 직접도말법, 집란법, 또는 특별한 염색법 등을 사용하
여 현미경으로 원충 감염을 진단한다. 그러나 이러한 방법은 노동 
집약적이며 매우 숙련된 검사자가 필요하다는 단점이 있다. 따라서 
높은 민감도와 특이도로 빠르면서도 편견 없는 결과가 필요함에 
따라 PCR 등을 이용한 분자생물학적 진단방법이 발전되어왔다. 
이 연구에서는 국내 검사실에서 장내 원충류 검사를 위해 Crypto-
sporidium parvum/hominis, G. lamblia 그리고 Entamoeba his-
tolytica를 검출하는 BD MAXTM Enteric Parasite Panel (EPP) (Bec-
ton, Dickinson and Company, USA)와 3개의 원충류에 추가적으
로 Blastocystis hominis, D. fragilis 그리고 Cyclospora cayeta-
nensis를 검출하는 AllplexTM Gastrointestinal Parasite Assays 
(AGPA) (Seegene Inc., Korea) 중 어느 것이 유용할지 비교해보고
자 하였다. 
방법: 저자들은 295개의 대변 검체들을 EPP와 AGPA를 사용하여 
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검사하였고 이 중 양성 결과를 확인하기 위해 일반 PCR 및 nested 
PCR을 이용하여 재검하였다. EPP 또는 AGPA의 결과 및 일반 PCR, 
Nested PCR에서 동일한 결과를 진양성으로 간주하였다. 
결과: 총 295개의 대변 검체에서 17개의 B. hominis 및 2개의 E. 
histolytica가 검출되었다. EPP는 검출 가능한 원충류 종류로 인한 
한계로 비록 2개의 원충만 검출하였으나 이는 100% (2/2) 진양성
이었다. AGPA는 총 24개의 검체에서 원충류를 검출하였으나 이 중 
진양성 및 위양성은 각각 79.2% (19/24), 20.8% (5/24)였다. 
결론: 원충류 감염, 특히 B. hominis의 감염은 예상보다 많을 수 
있다. 따라서 AGPA는 원충류 감염의 스크리닝 목적으로 사용될 
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